🔎 Trials Near Me

Akèy › Mediloblastom › Alabama

Etid klinik pou Mediloblastom nan Alabama

3 etid pou Mediloblastom ap chèche patisipan nan sit nan Alabama.

Tèks ofisyèl etid la (Anglè)

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

  • University of Alabama at Birmingham Cancer Center, Birmingham
Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388

Digoxin Medulloblastoma Study

  • University of Alabama at Birmingham Children's of Alabama, Birmingham
Ap rekriteFaz 2
12 Months – 30 Years · Tout sèks · Mizajou Aug 26, 2026 · NCT06701812

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

  • USA Health Strada Patient Care Center, Mobile
Ap rekriteFaz 3
Laj 4 a 21 · Tout sèks · Mizajou Aug 25, 2026 · NCT05382338

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.